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This work evaluates the efficiency position of the health system of each OECD country. 
It identifies whether, or not, health systems changed in terms of quality and 
performance after the financial crisis. The health systems performance was calculated 
by fixed-effects estimator and by stochastic frontier analysis. The results suggest that 
many of those countries that the crisis affected the most are more efficient than the 
OECD average. In addition, some of those countries even managed to reach the top 
decile in the efficiency ranking. Finally, we analyze the stochastic frontier efficiency 
scores together with other health indicators to evaluate the health systems’ overall 
adjustments derived from the crisis. 
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The impact of the 2008 crisis on health care has heightened the need to make 
appropriate investment in health quality and to reinforce financial sustainability of the 
health care systems. Of particular interest is the health care systems efficiency and 
health care restructurings and improvements in order to cope with the impact of the 
economic crisis. 
Health systems efficiency has been studied for a period before the crisis by Joumard et 
al. (2010). They found that in the OECD countries higher health care expenditures did 
not necessarily mean better health status. There was indeed efficiency shortage in some 
countries. Based on the results, recommendations for improvements were specified for 
each country’s health system.  
However, it is not clear whether the budgetary constraints and health reforms resulting 
from the crisis changed those findings. 
The purpose of this research is to analyze how health systems efficiency in the OECD 
countries have adjusted after the crisis. Answering the main question will imply 
evaluating the recent relative position of each country in the OECD health system 
efficiency ranking. An analysis similar to Joumard et al. (2010) was done using 2005-
2011 data, for 33 OECD countries. Moreover, it is important to observe in which 
aspects health care systems are doing better and in which they are doing worse than 
before 2008, so that weaknesses that prevent a better performance can be identified.  
The results show that several countries changed their efficiency score after the crisis. 
Some of those countries that the crisis affected the most increased their relative position 
in the efficiency ranking. Moreover, the results show that if all countries improve the 
system performance to the level of the most efficient county, the OECD average life 
expectancy at birth of total population can increase by almost two years.  
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This paper is structured in the following way. Section II presents some previous 
empirical work in assessing health care systems efficiency, section III describes the 
methodology and data which is used. Then, the health status determinants, the 
efficiency results as measured by both fixed-effects estimator and stochastic frontier 
approaches, the health indicators comparison by groups of countries and the change on 
the health care profile of each country are presented in section IV. Finally, we present 
work limitations and conclusions in section V. 
II. Literature Review 
As the main objective is to have a direct comparison with the work of Joumard et al. 
(2008, 2010), these studies are the starting point. They calculated health care systems 
efficiency scores of 30 OECD countries by two methods: fixed-effects estimator, over 
the period of 1981-2003, and data envelopment analysis, using data for 2007. They 
found that on average, OECD countries could increase life expectancy at birth by 2 
years if all became as efficiency as the best performer. The efficiency scores were 
compared with other health indicators, particularly with those reflecting the activity and 
quality of the health care system. 
By cluster analysis, countries were grouped, in 6 groups, based on their health care 
system’s characteristics in the form of several indicators transformed from the answers 
of 29 countries to the OECD Survey on Health Systems Characteristics 2009. So that, 
all health indicators would be analyzed by comparing each country not only with the 
OECD average, but also with its group of countries with similar health system 
characteristics. It was also found that there was no health system type considerably 
better than the others. The efficiency level had a higher variance within each group than 
between groups. 
There has been a great focus in the literature on assessing health efficiency at national 
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and international system level, as well as at hospital level within countries, by taking 
different approaches. The Canadian Institute for Health Information (2014) also 
measured the health care efficiency and its determinants for the different regions in 
Canada using data envelopment analysis. And they found that there were regional 
differences in performance and that by maximizing their efficiency, regions could on 
average reduce treatable causes of death by 18% to 35%. They also found that less 
smoking, obesity and chronic conditions, shorter lengths of stay, more equity in health 
access and more primary care investment have significant impact on regional efficiency. 
Alternative approaches to measure performance of health care have been taken in other 
studies. WHO (2000) and Evans et al. (2000) studied the health care system efficiency 
of 191 countries for 1997, by a stochastic frontier analysis, taking the Disability-
Adjusted Life Expectancy as health status of the population. Murray and Evans (2003) 
pointed out that the stochastic frontier analysis is more appropriate in efficiency 
measurement than the data envelopment analysis, since the latter method attributes all 
the distance to the frontier as inefficiency, not taking into account random factors.  
Jourmard et al. (2008) created a health production function and found that health 
spending is the factor that affects the most the health status of a population, followed by 
education. They found that a 10% increase in health spending increases life expectancy 
at birth by 3 to 4 months, keeping everything else constant. On the other hand, Thornton 
(2002) presented empirical evidence for the USA that socioeconomic status, such as 
education, income and married households have more impact on the health status of the 
country, in this case, age-adjusted death rate, than health spending. 
III. Data and Methodology 
Given that it was not feasible to use the exact same variables as in Joumard et al. (2008, 
2010), there is one modification in the production function’s input, one lifestyle variable 
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was removed from the original model of Joumard et al (2008, 2010). The efficiency was 
estimated by two approaches: 1) regressions using panel data and estimated by fixed-
effects and 2) stochastic frontier analysis, SFA (as opposed to data envelopment 
analysis that was used in the above-mentioned literature). Moreover, three OECD 
countries, Estonia, Israel and Slovenia were not analyzed by Joumard et al. (2008, 
2010), but they are included in this paper.  
Similarly to the work of Joumard et al. (2010), the efficiency scores were analyzed 
together with those indicators that reflect the quality of preventive and out-patient care 
sectors (vaccination, avoidable hospital admission and acute myocardial infarction and 
stroke fatality rates), the hospital output efficiency (in-patient average length of stays, 
acute care occupancy and turnover rates, cataract surgeries and consultations per 
doctor), equity in health status, amenable mortality rates (those deaths due to causes that 
could potentially be avoided with the effective treatment at the right time) and 
administration costs, which are useful to assess the health system efficiency of each 
country. Other indicators included in the country profiles are related to health care 
prices and spending per capita and to GDP, number of health professionals and their 
respective income, hospital physical resources (high-tech equipment and hospital beds), 
hospital activity (doctor consultations per capita, hospital discharges and some surgery 
procedures), pharmaceutical consumption, nature of health care financing (public, 
private insurance, out-of-pocket) and spending destination sectors (in-patient, out-
patient, medical goods). All these indicators (Table 1) were not considered as inputs in 
the health production function, because these indicators are hospital’s output-based 
efficiency indicators. Yet they are a complement in the study of the system (outcome-
based) efficiency determinants.  
Although most indicators were retrieved from the OECD Health Data, some had to be 
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developed by calculations for this paper. For comparison purposes, the same proxy for 
health status equity was calculated as in Joumard et al. (2010), by the inverse of the 
standard deviation in the age of death for population aged above 10, using data on 
number of deaths by age from the Human Mortality Database. This age dispersion was 
proposed by Edwards and Tuljapurkar (2005) as a proxy for health inequalities in health 
status. An output efficiency indicator, the acute care turnover rate, was also calculated, 
by dividing the number of acute discharges by the number or available acute care beds. 
Table 1 - Health care indicators by area 
Efficiency and quality Amenable mortality 
 SFA efficiency score 
 Equity score 
 Average length of stay 
o All in-patient; Colorectal cancer; Lung cancer; Breast 
cancer; Acute myocardial infarction; Femur fracture 
 Acute occupancy rate 
 Acute turnover rate 
 Cataract surgery 
 Consultations per doctor 
 Expenditure in health administration 
 Vaccination rates 
o Diphtheria, tetanus and pertussis; Measles; Influenza 
 Avoidable hospital admission rates 
o Asthma; Bronchitis; Heart Failure 
 In-hospital case fatality rates 
o Acute myocardial Infarction; Ischemic stroke 
 All causes  
 Infectious diseases 
 Cancers 
 Endocrine, nutritional and metabolic 
diseases 
 Diseases of nervous system 
 Diseases of circulatory system 
 Diseases of genitor-urinary system 
 Diseases of respiratory system 
 Diseases of digestive system 
 Perinatal mortality 
Prices and physical resources Activity and consumption Financing and spending 
 Total health expenditure  
 Practicing physicians  
 Practicing nurses 
 Medical graduates 
 MRI units 
 Computed tomography 
scanners 
 Number of acute care beds 
 Remuneration of hospital 
nurses  
 Remuneration of general 
practitioners 
 Remuneration of specialists  
 Relative health prices to GDP 
 Doctor consultations 
 Hospital discharges 
 Hip replacement 
 Knee replacement 
 Appendectomy 
 Caesareans sections  
 Antidepressants  
 Anxiolytics  
 Analgesics  
 Anti-inflammatory, 
antirheumatism 
 Antibacterials for systemic use  
 Cardiovascular system  
 Drugs for diabetes 
 Public spending  
 General government funding  
 Social security funding 
 Private health insurance funding 
 Out-of-pocket payments 
 Expenditure on medical goods 
 Expenditure on out-patient care 
 Expenditure on in-patient  
 Expenditure on collective services 
(public health services and health 
administration) 
Source: Joumard at al. (2010) 
To calculate the efficiency of the health systems, a production function was designed for 
the health care at the system level.  
The production function’s output and input data were retrieved from OECD Health Data 
2014. A panel data covering 7 years was analyzed, focusing in the time between 2005 
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and 2011, for the majority of the variables. The purpose was to get as many years before 
as after the financial crisis of 2008. 
As the output at the system level, life expectancy at birth, for females, males and both, 
and life expectancy at age 65 for each gender were the variables used as proxy for the 
health status of each countries’ population. Life expectancy at birth for both genders 
was considered the dependent variable for the efficiency calculations, by both fixed-
effects estimator and stochastic frontier approaches. Other proxies could be thought as 
more desirable as one assumes that it is important to take into account the quality of life 
of the population (Joumard et al., 2008). However, regarding all possible health status 
indicators, longevity data was the most complete one.  
Health status depends on the quantity of medical care services that is offered to the 
population, thus the variable used as its proxy was total health expenditure per capita 
US$ PPP rates. Moreover, the health care that the population receive over the years also 
influence the current health status. Therefore, a variable with the cumulative value of 
health investment was also considered as a variable of health stock of the previous three 
years. It has been debatable whether a discount rate for healthcare should be taken into 
account, and at what value (Acharya and Murray, 2003; Stahl, 2004), therefore the ad-
hoc discount rate of 10% was chosen. 
Two population’s lifestyle indicators (alcohol and diet) were used as control variables in 
the fixed-effects estimator. Alcohol consumption in liters per capita was introduced as a 
1-year lag variable, as the current level of alcohol consumption may have an impact in 
health status, but alcohol data for all countries is only complete until 2010. A proxy for 
diet, consumption of fruits and vegetables in kilograms was also taken into account in 
the production functions.  
It would be appropriate to include a variable of tobacco consumption, however it was 
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not possible to do it since ten of the thirty-four OECD countries could not be analyzed. 
Data for tobacco consumption in grams per capita is nonexistent for Chile, Estonia, 
Luxembourg, Mexico, Slovakia and Slovenia and is missing for several other countries, 
either in recent years or in lagged values. Other alternative measures of tobacco 
consumption (e.g. share of daily smokers; number of cigarettes smoked per day) also 
present missing data for many countries.  
The exogenous variables’ set also included one environmental factor affecting 
population’s health: emissions of nitrogen oxide in kilograms per capita. This factor 
represents air pollution in each country which especially affects the respiratory system, 
and so may affect life expectancy.  
Education and income are the two socioeconomic variables taken into account in the 
models. The education variable is measured by the share of adult population with at 
least upper secondary school. Income is measured by the GDP per capita US$ PPP rate. 
The regressions by fixed-effects estimator were the first approach used to calculate the 
efficiency ranking,1 allowing for a direct comparison with Joumard et al. (2008, 2010). 
And were also the main approach used to verify the impact of health expenditure on the 
health status of the population of each country, while controlling for other lifestyle and 
socioeconomic variables (alcohol consumption, diet, pollution, education and GDP). 
Life expectancy at birth for females, males and both, and life expectancy at age of 65 
for females and males were the dependent variables for the analysis of impact of each 
independent variable. However, to get the efficiency score only life expectancy at birth 
for total population was taken as the dependent variable. Moreover, all variables 
included in the regressions were transformed in logarithms.  
The assumption of this method by fixed-effects estimator is that what is not accounted 
                                                          
1 Cameron, A. Colin, and Pravin K. Trivedi. (2005). “Linear Panel Models: Basics” Microeconometrics: 
methods and applications, 697-726. Cambridge University Press. 
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for by the model reflects the health care system efficiency of the country (Joumard et 
al., 2008). This efficiency score was calculated by adding up the country fixed-effects to 
the residuals of the latest year in study. This sum measures the distance to the 
production frontier. Thus, it was assumed that the country fixed-effects are part of the 
country inefficiency, and are not revealing a different production frontier for each 
country. 
The alternative methodology of this paper to calculate the inefficiency score is the 
Stochastic Frontier Analysis (SFA).2 The frontier is the maximum outcome (health 
status) that is possible to reach given the level of inputs in use. This method allows to 
make the distinction between the part of the residual that is due to random factors and 
the part of the residual that accounts for the country inefficiency. The production 
function used was the same one as in the regressions with fixed-effects estimator 
referred above. The same output and inputs transformed in logarithms were included. 
Modeling the production frontier with panel data increases the number of observations 
and accuracy of estimates. This way, it is feasible to calculate the system inefficiency by 
analyzing the frontier with country fixed-effects incorporated into the inefficiency 
equation, which is compatible with the previous approach by fixed-effects estimator. 
Besides, with a stochastic frontier model using fixed-effects there is no need to make 
any assumptions about the inefficiency term’s distribution, which makes this method 
less restrictive (Murray and Evans, 2003). 
Although the efficiency was calculated for 2011 by both methods, there were two 
exceptions that had different latest years available: for Korea and Mexico the score was 
calculated for 2010 and 2008, respectively.   
                                                          
2 Coelli, Timothy J., D.S. Prasada Rao, Christopher J. O'Donnell, and George E.  Battese. (2005). 




For Chile, education data is missing for 2005 and 2006 and data of nitrogen oxide 
emissions is missing for the rest of the studied years, therefore it is the only OECD 
country not being analyzed here. 
In this work it was assumed as reasonable to compare efficiency scores and other health 
indicators within and across the group of countries with similar health care system 
characteristics that are resulting from the Survey on Health Systems Characteristics 
2008-2009 analysis made by Joumard et al. (2010). Although there is some new data for 
countries’ health policy and institutions, from the Survey on Health Systems 
Characteristics 2012, this data was not as complete. More recently, other authors (e.g. 
Pisu, 2014 and Tchicaya and Lorentz, 2014) analyzed health care sectors and systems 
using the indicators of system characteristics that result from Joumard et al. (2010) and 
other data from the Survey on Health Systems Characteristics 2008-2009.  
IV. Results 
The economic crisis in mid-2008 had a visible impact on the OECD average health 
spending per capita, US$ PPP. On average the health spending growth decreased after 
2008, especially between 2009 and 2010 when the average growth rate was close to 
zero. However, some countries actually decreased their total health spending per capita 
after the crisis, namely Czech Republic, Estonia, Greece, Iceland, Ireland, Portugal, 
Slovak Republic, Slovenia, Spain, Turkey and United Kingdom. Some of those still had 
negative health spending growth in 2011: Greece, Ireland, Portugal, Slovak Republic 
and Spain (Morgan and Astolfi, 2014). 
Now we know how the main health sector input evolved, therefore it is important to 
understand the impact of this and other non-health sector inputs on the health status, as 
well as, what happened to the efficiency of these countries individually.  
IV.1 Health status determinants 
The presented regressions’ output resulted from fixed-effect estimator with robust 
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standard errors.3   
Table 2 indicates that a country has higher life expectancy at birth of total population if 
it spends more in health care, has more adults with at least upper secondary education 
and less air pollution. These coefficients are statistically significant, at the 1% or 5% 
level, for life expectancy at birth of total population, i.e. for both female and male.  
Table 2 – Fixed-effects estimator output: Health status determinants 
 
The variables’ coefficients in the regressions have the expected signs. The exception is 
the coefficient for diet, consumption of fruits and vegetables, which has a negative 
impact in health status. However its impact is not statistically significant. 
In this period of 2005-2011, the regressions output reveal that for total population 
income per capita and the lifestyle variables, alcohol and fruits and vegetables 
consumption, are not significantly different from zero and that education is the variable 
with the highest elasticity. This may be due to higher education meaning more access to 
health information and a better understanding of it by the patients which may have 
impact on the efficacy of medical services (Thornton, 2002). Nevertheless, the OECD 
                                                          
3 There may be some endogeneity effect, as the level of total healthcare expenditure is a function of the 
income level. Table A.2 in appendix shows that by excluding the variable of GDP in the fixed-effects 
estimator regressions, the coefficient of health spending increases, suggesting that the variable of 
spending includes the income effect not related to health, which may lead to biased estimators. For this 
reason and for the lack of reliable instrumental variables, Joumard et al. (2008) included both health 
spending and GDP variables in their model. In this paper, we also included them for comparison reasons.  
* p<0.10, ** p<0.05, *** p<0.01
                                                                                                    
N                             225             225             225             225             225   
R-sqr                       0.798           0.785           0.807           0.802           0.825   
                                                                                                    
                           (0.06)          (0.06)          (0.05)          (0.22)          (0.25)   
constant                    3.952***        3.898***        3.923***        1.859***        1.727***
                           (0.01)          (0.02)          (0.01)          (0.02)          (0.03)   
logGDP                      0.015*          0.014           0.014           0.039*          0.043   
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.02)   
logNOx                     -0.010          -0.018*         -0.013*         -0.048**        -0.069***
                           (0.01)          (0.01)          (0.01)          (0.04)          (0.03)   
logEdu                      0.045***        0.033***        0.039***        0.136***        0.088***
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.02)   
logDiet                    -0.004          -0.003          -0.003          -0.016          -0.014   
                           (0.01)          (0.02)          (0.01)          (0.03)          (0.04)   
logAlcohol                 -0.014          -0.027*         -0.021          -0.042          -0.060   
                           (0.01)          (0.02)          (0.01)          (0.02)          (0.03)   
logSpending                 0.024**         0.036*          0.030**         0.064**         0.089***
                                                                                                    
                             b/se            b/se            b/se            b/se            b/se   
                     Female birth      Male birth     Total birth        Female65          Male65   
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average of life expectancy at birth of total population may increase 2.86 months if the 
average spending increases by 10%, keeping everything else constant. 
Table A.3 in appendix presents another specification of the model including a variable 
of health stock. However, the stock of investment in health is highly correlated with the 
current health spending (Table A.4 in appendix). Thus, the variable of health stock was 
not included in the main model of efficiency measure. 
IV.2 Fixed-effects estimator – Efficiency ranking 
By taking life expectancy at birth for total population as the dependent variable, the 
fixed-effects and the residuals specify the years of life gained or lost compared to those 
years of life expectancy that were expected if the country had the same efficiency as the 
OECD average. Which means that, by these assumptions, Austria has the average 
efficiency, while Spain’s high efficiency allows it to get 4 more years compared to the 
(average) output that was expected by the model. On the other hand, the United States 
of America is the OECD country with the least efficient healthcare system, according to 
the fixed-effects estimator method, losing 4 years of life expectancy compared to the 
expected output. Figure 1 presents these deviations in years of life expectancy at birth 
for total population, resulting in the ranking of countries’ health system efficiency. 
Figure 1 - Country fixed-effects and residuals deviation from OECD average, 2011: 



































































































































































































Comparatively to the 2003 efficiency results from Jourmard et al. (2008, 2010), 
measured by fixed-effects estimator under the same assumptions (Figure A.1 in 
appendix), it is possible to notice that, for 2011, there were some changes on the relative 
position of this efficiency ranking. The results displayed in Figure 1 indicate that, taking 
into account only those 23 countries studied by fixed-effects estimator in Joumard et al. 
(2008, 2010), Poland and Sweden went down considerably in the ranking, while United 
Kingdom and Austria became more efficient than the average. 
IV.3 Stochastic Frontier Analysis – Efficiency scores 
By the second method, the stochastic frontier analysis, the resulting inefficiency scores 
were converted into years of life expectancy that the country can potentially gain if it 
increases its efficiency to the level determined by the frontier (Table A.5 in appendix 
shows the SFA coefficients). By incorporating country fixed-effects into the model, 
typically one or more countries are in the frontier and assumed as being totally efficient, 
while the other countries are analyzed by comparison to those efficient ones 
(Kumbhakar and Lovell, 2000).  
Figure 2 - Potential gains in years of life expectancy (Stochastic Frontier Analysis) 
 
In this case, the countries that are completely efficient are, Japan, Spain, Greece, Korea 
and Australia, their observed output is placed on the production frontier. While Turkey, 
Mexico and Hungary could increase their total population life expectancy at birth by 





























































































































































































IV.4 Fixed-effects estimator vs Stochastic frontier 
For the calculations of the potential gains in life expectancy by both methods, the 
reference is the most efficient country. These scores result from comparing each country 
with the most efficient one.  
Figure 3 - Potential gains in years of life expectancy at birth:  Fixed-effects estimator 
and Stochastic Frontier analysis plot 
  
Although there are some changes on efficiency ranking places, the results are similar in 
terms of which countries are the most efficient ones and which ones are the least 
efficient (Figure 3). However, the maximum number of years a country can potentially 
increase its life expectancy is 1 year lower by the stochastic frontier method than by the 
fixed-effects estimator method. Additionally, by the stochastic frontier analysis, the 
potential gains of life expectancy at birth are, on average, 1 years and 8 months, but by 
the fixed-effects estimator, the average potential gains is 3 years and 8 months. 
From those countries with negative health spending growth in 2011, Spain, Portugal, 
Greece and Ireland have above OECD average efficiency, while Slovak Republic is the 
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IV.5 Changes within and across groups 
From those six groups of countries with similar health systems characteristics resulting 
from the work of Joumard et al. (2010),4 the same analysis comparing efficiency scores, 
as measured by the stochastic frontier, within and between groups was done. The 
analysis showed that there are efficient and inefficient countries (above and below 
OECD average efficiency) in every group (Figure 4). Moreover, as presented in Table 3, 
the number of years of life expectancy a country could gain by increasing its efficiency 
to the frontier level has higher variance within groups than between groups. These 
conclusions correspond to the results for 2007, from Joumard et al. (2010), emphasizing 
once again that no health system type has necessarily better performance than the 
others.   
From the 2011 results in Figure 4 and Table 3, it is possible to compare the 2007 results, 
presented in Figure A.2 in appendix, from similar work done by Jourmard et al. (2010). 
Yet, some OECD countries which efficiency was analyzed for 2011, can still not be 
included in the analysis of this section.  This is the case of Estonia, Israel, Slovenia and 
United States of America, since they did not participate in the Survey on Health 
Systems Characteristics 2008-2009, therefore it was not possible to group them for their 
health system characteristics like the other countries.  
Within group 1 (Germany, Netherlands, Slovak Republic, Switzerland), only the 
                                                          
4 Group 1 is composed by countries that rely on market mechanisms at the provider level and a high share 
of private basic insurance. 
Group 2 is composed by countries that rely on market mechanisms at the provider level, public basic 
insurance, private over-the-basic insurance and gate-keeping. 
Group 3 is composed by countries that rely on market mechanisms at provider level, public basic 
insurance, little private over-the-basic insurance and no gate-keeping. 
Group 4 is composed by countries that rely mostly on public provision and insurance, no gate keeping 
and wide choice of providers. 
Group 5 is composed by countries that rely on public provision and public insurance, gate-keeping, 
limited choice of providers and soft budget constraint. 
Group 6 is composed by countries that rely on public provision and insurance, gate-keeping, wide choice 
of providers and strict budget constraint. (Joumard et al., 2010) 
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Netherlands’ efficiency score shifted to above average, but the group mean efficiency 
after the crisis is still worse than the OECD average. Switzerland still has the highest 
efficiency, while the least efficient country is represented by Slovak Republic.  
Figure 4 - Potential gains in life expectancy at birth across and within country groups 
plot (Stochastic Frontier Analysis) 
 
Table 3 - Potential gains in life expectancy at birth within and across groups: mean and 
variance (Stochastic Frontier Analysis) 
Group of countries with similar system characterisitics 
Potential gains in years of 
life expectancy 
Mean Variance 
1: Germany, Netherlands, Slovak Republic, Switzerland 2,1 3,7 
2: Australia, Belgium, Canada, France 0,6 0,8 
3: Austria, Czech Republic, Greece, Japan, Korea, Luxembourg 0,7 1,3 
4: Iceland, Sweeden, Turkey 2,5 13,6 
5: Denmark, Finland, Mexico, Portugal, Spain 2,2 6,4 
6: Hungary, Ireland, Italy, New Zealand, Norway, Poland, United Kingdom 1,8 4,1 
Total 1,6 3,9 
Intra-group - 4,4 
Inter-group - 0,5 
 
Group 2 (Australia, Belgium, Canada, France) has seen some small changes where 
Canada and France improved their performance and are now in quite high and very 
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efficient countries, respectively. This group keeps having a better mean performance 
than the OECD average and has now the highest performance among the groups.  
The third group (Austria, Czech Republic, Greece, Japan, Korea, Luxembourg) had 
efficiency improvements in general, especially the major increase of Greece’s 
efficiency, that in 2011 is the highest of the group together with Japan and Korea. 
Austria is also performing well and Luxembourg improved and is now very close to 
Austria’s efficiency level. The worst performer of this group is now Czech Republic 
that keeps below average after the crisis.  
The forth group, composed by Iceland, Sweden and Turkey, had the highest mean 
efficiency, in 2007. However, it has now a lower mean efficiency and is the group with 
the highest score variance. Iceland and Sweden continue performing well, however after 
the crisis, Turkey had a great decrease of performance and goes from the highest to the 
lowest efficiency score of this group.  
Concerning group 5 (Denmark, Finland, Mexico, Portugal, Spain), Spain and Portugal 
continue to have high efficiency levels and Finland has improved its performance since 
2007. Denmark is still performing below the OECD average. Mexico has the most 
extreme change of position as it goes from being the most efficient country to the least 
efficient one of the fifth group. This leads to a low group mean efficiency. 
The countries of group 6 (Hungary, Ireland, Italy, New Zealand, Norway, Poland, 
United Kingdom) are still performing worse than the OECD average. Although Italy 
and Hungary continue being the highest and the lowest performers, respectively, there 
were some shifts in this group after the crisis. In 2011, Ireland, United Kingdom and 
New Zealand have above average scores, while Norway and Poland are performing 
worse than before. 
Taking the stochastic frontier efficiency scores of each country into account and 
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comparing them with the OECD average and with the previous results measured by data 
envelopment analysis (Figure A.2 in the appendix) from Jourmard et al. (2010), it is 
possible to verify that, after the crisis, most of those countries with high or low 
efficiency keep similar relative positions. Moreover, Spain and Italy became even more 
efficient than in 2007. Nevertheless, some other countries changed from their inefficient 
situation and became more efficient than the average, namely Greece, Ireland, New 
Zealand, Austria, Finland, Netherlands Luxembourg and United Kingdom. While 
Mexico, Turkey, Poland and Norway decreased their position and became inefficient.  
IV.6 Other health indicators – group comparison  
On average, the inequalities in health status, measured by the standard deviation of the 
age of death for population aged above 10, increased almost 1 standard deviation after 
the crisis (Figure 5). The group with the lowest average of inequalities is now group 1, 
composed by Germany, Netherlands, Slovak Republic and Switzerland. While group 2 
still has on average the highest level of inequalities. Comparatively to 2007, there were 
some changes within groups. In group 1, the country with the highest level of 
inequalities continues to be Slovak Republic, however the one with the lowest level is 
now Germany. In 2011, group 2 has Australia as the country with the most inequalities 
and Belgium with the lowest. In group 3, Luxembourg became the country with the 
highest inequalities, however, Japan passed from having the highest level to the lowest 
of the group. In group 4 it is now possible to notice the highest within group variation, 
between the high level of inequalities of Iceland and the low level of Sweden. Group 5 
appears as the only group without changes in inequalities ranking. While in the sixth 
group, Italy keeps having the lowest inequality levels, but Ireland became the country 
with the highest level.  
In 2011, the OECD average life expectancy at birth is 80 years (Figure 6). With the 
exception of group 2, which is only composed by countries with life expectancy that is 
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higher than the OECD average, every group have wide within variations, since they 
include countries with both above and below average life expectancy.  
Figure 5 - Inequalities in health status across country groups of health system 
characteristics, 2011 (or latest year available) 
 
Source: Human Mortality Database. 
Figure 6 - Total population life expectancy at birth across country groups of health 
system characteristics, 2011 (or latest year available) 
Source: OECD Health Data 2014.  
Figure 7 - Total Health expenditure per capita, US$ PPP across country groups of 
health system characteristics, 2011 (or latest year available) 
 
Source: OECD Health Data 2014. 
Figure 8 - Administrative costs across county groups of health system characteristics, 
2011 (or latest year available) 
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Total health expenditure per capita continues to be higher on average in groups 1 and 2. 
The forth group has the lowest spending on average, with contribution of Iceland’s great 
health expenditure decrease in 2010 (Figure 7). 
In general, in 2011 the OECD average administrative costs in percentage of total health 
spending decreased. The countries that in 2007 had this percentage much higher than 
the average decreased it considerably after the crisis. For instance, Luxembourg had the 
second highest percentage of administration costs before, however, it is now among the 
countries with the lowest percentage (Figure 8). 
IV.7 Health indicators comparison between 2007 and 2011 
To complement the countries’ profile, the stochastic frontier efficiency scores were 
analyzed together with other health indicators. In this section, we compare the recent 
levels of the health indicators with those 2007 levels studied by Joumard et al. (2010).  
In Table 4, we compare each country against the OECD average, pointing out the main 
changes occurring after the crisis. Some of the recommendations presented in the 
previously referred work were taken into account to verify whether they were followed 
by the countries or not. Moreover, we present the potential total health savings per 
capita, US$ PPP, for the countries that are not totally efficient. The potential health 
savings were estimated by the change on health spending that leads the country to the 
efficiency frontier, keeping the same life expectancy level and the other inputs constant. 
The health care indicators are divided by areas, the same ones as those in Joumard et al. 
(2010): efficiency and quality; amenable mortality; health prices and physical resources; 
activity and consumption; financing and spending.  
Besides a high efficiency score, one would consider the ideal health care system as the 
one having low inequalities in health status, low amenable mortality rates, low 
administrative costs, short average length of stay, high quality of service provision, an 
appropriate number of health professionals for the level of health demand and a 
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balanced share of resources between sectors. 

















Potential total health savings/ 


















- Reducing length of stay of in-



















- Increasing quality 
Not totally achieved: 
- Rebalancing in-patient and 
out-patient resources 
Potential savings: 1198.15$ 















- Increase hospital efficiency;  
- Reducing number of doctor 
consultations;  
- Reducing administrative costs 
Potential savings: 2782.79$ 


































- Reducing number of doctor 
consultations; 
- Improving quality 
Potential savings: 1667.58$ 

















- Decreasing the excessive 
demand to general practitioners 
Potential savings: 3358.31$ 

































Potential savings: 1126.79$ 













- Increasing spending share on 
out-patient care 
Not achieved: 
- Decreasing inequalities; 
- Improving out-patient care 
quality 
                                                          
5 Due to the low elasticity (spending coefficient), small measurement errors, long-term effects of health 
spending and low total variation in life expectancy may have huge impact in the potential savings. This 



















Potential total health savings/ 
capita (US$ PPP)5 
Potential savings: 1777.20$ 
















- Decreasing health status 
inequalities; 


















- Adjusting policies to avoid 
excessive hospital activity 
Potential savings: 3023.68$ 


































   
Achieved: 
- Decreasing inequalities 
Not achieved: 
- Rebalancing resources from 
medical goods to in-patient and 
out-patient care 
Potential savings: 1744.54$ 


























- Control health care spending; 
- Reducing spending on in-
patient care; 
- Reducing number of human 



















Potential savings: 1830.69$ 
























Potential savings: 198.82$ (9% 















- Improving efficiency on the 
in-patient care sector 
Potential savings: 6.17$ 












- Reducing length of stays in 
acute and in-patient care;  



















Potential total health savings/ 






- Improving quality  
Potential savings: 490.47$ 







   
Not achieved: 










   
Not achieved: 
- Improving in-patient care 
efficiency; 
- Increasing out-of-pocket 
payments 
Achieved: 
- Reducing administrative costs 
Potential savings: 1353.62$ 























- Improving health status of the 
population; 
- Reducing administrative costs 
Potential savings: 861.82$ 





   
Potential savings: 2937.78$ 













- Reducing inequalities; 
- Reducing high administrative 
costs; 
- Improving hospital  efficiency 
Potential savings: 313.51$ 














- Reducing number of doctors 
for the needs of the population 
Potential savings: 3695.81$ 
















- Decreasing inequalities; 
- Increasing hospital efficiency; 
- Increasing quality of care  
Potential savings: 1239.46$ 













- Improving efficiency of in-
patient sector;  
- Increasing number of 
consultations/ doctor; 
- Improving quality of care  
Potential savings: 1102.35$ 








quality of care 
   
Not achieved: 
- Increase remuneration of 
health professionals to increase 
quality of care 
Potential savings: 1888.70$ 















Potential savings: 928.23$ 



















Potential total health savings/ 
capita (US$ PPP)5 





























Not achieved:  











- Improving quality 
Not achieved: 
- Reducing number of doctors 
for the low number of doctor 
consultations 
Potential savings: 1318.64$ 











- Containing health care prices  
Potential savings: 852.24$ 




















- Containing level of public 
health spending 
Potential savings: 921.09$ 

















- Improving quality 
Potential savings: 1016.29$ 


























Potential savings: 7842.58$ 
(92.5% of health spending) 
Source: OECD Health Data 2014; Human Mortality Database; Joumard et al. (2010) 
V. Conclusions and Limitations 
The levels of adult education and of health expenditure are highly associated with the 
health status of the population. Keeping everything else constant, a ten percent increase 
on the OECD average of total health expenditure increases life expectancy at birth of 
total population by almost 3 months, on average.  
The economic crisis has appeared for many countries as a challenge for the health care 
system. The crisis required budget controls in most countries, while keeping and/or 
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increasing the same level of quality and coverage of health care services. Therefore, the 
crisis was an opportunity to create reforms that changed several health care systems 
efficiency. Six OECD countries, Greece, Ireland, Austria, New Zealand, United 
Kingdom, Finland, Netherlands and Luxembourg increased their position relative to the 
average, while four countries, Norway, Poland, Mexico and Turkey decreased it. 
Southern European countries, like Spain and Greece, economies where the crisis had a 
great socioeconomic impact and where expenditure controls were essential, show up as 
countries that reached the top health care system efficiency. Although, these countries 
decreased the total health spending per capita after the crisis, there was no immediate 
effect on the health status of their population. Nevertheless, if all countries increase 
their efficiency to the efficiency level of the best performer, the OECD average life 
expectancy at birth of total population can still increase by almost two years. 
However, the non-inclusion of tobacco consumption, due to lack of data, on the health 
production function can have some efficiency implications. This can be especially 
challenging in the fixed-effects estimator approach, since the assumption of including 
the residuals in the efficiency score disregards the possibility of measurement errors or 
other random factors. 
Moreover, both methods of efficiency calculation, imply the comparison of the 
countries to the best performing country. Though, the best health system derived from 
the calculations does not necessarily have the best achievable performance in theory. 
This means that the efficiency scores are overestimated and the top performer can 
improve and reach even higher levels of efficiency and quality in the health care.  
However, higher accessibility of health data, namely lifestyle and quality indicators 
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Table A.1 – Definition of the health indicators 
 
Efficiency and quality indicators Definition  
SFA efficiency score The inefficiency translated in years of life expectancy, 
resulting from the stochastic frontier analysis with one 
output (life expectancy at birth) and six inputs (health 
spending, alcohol consumption, diet, education, pollution 
and income). 
Equity score The inverse of the standard deviation of the age of death 
for population aged above 10 
Average length of stay – All, in-patient The ratio between number of bed-days and number of 
discharges 
Average length of stay – Colorectal cancer The ratio between number of bed-days and number of 
discharges – cases of malignant neoplasm of colon, rectum 
and anus 
Average length of stay – Lung cancer The ratio between number of bed-days and number of 
discharges – cases of Malignant neoplasm of trachea, 
bronchus and lung 
Average length of stay – Breast cancer The ratio between number of bed-days and number of 
discharges – cases of malignant neoplasm of breast 
Average length of stay – Acute myocardial infarction The ratio between number of bed-days and number of 
discharges – cases of acute myocardial infarction 
Average length of stay – Femur fracture The ratio between number of bed-days and number of 
discharges – cases of fracture of femur 
Acute occupancy rate Percentage of the curative care beds that are occupied  
Acute turnover rate The ratio between number of acute discharges and the 
number of available acute care beds 
Cataract surgery Total number of surgical procedures 
Consultations per doctor Number of consultations per doctor 
Expenditure in health administration Percentage of the total health expenditure that is addressed 
to administrative cost 
Vaccination rates – Diphtheria, tetanus and pertussis Percentage of children immunized against diphtheria, 
tetanus and pertussis 
Vaccination rates – Measles Percentage of children immunized against measles 
Vaccination rates – Influenza Percentage of population aged 65 and over immunized 
against influenza 
Avoidable hospital admission rates – Asthma  Hospital admission rates for cases of asthma of population 
aged 15 and over. (These admissions are considered 
avoidable, because it is assumed that most asthma cases 
could be handled without hospitalization.) 
Avoidable hospital admission rates – Bronchitis  Hospital admission rates for cases of chronic obstructive 
pulmonary disease of population aged 15 and over. (These 
admissions are considered avoidable, because it is 
assumed that most bronchitis cases could be handled 
without hospitalization.) 
Avoidable hospital admission rates – Heart Failure Hospital admission rates for cases of congestive heart 
failure of population aged 15 and over. (These admissions 
are considered avoidable, because it is assumed that most 
congestive heart failure cases could be handled without 
hospitalization.) 
In-hospital case fatality rates – Acute myocardial 
Infarction (AMI) 
The ration between the number of deaths that occurred 
within 30 days of hospital admission with acute 
myocardial infarction and the number of admissions of 
AMI cases 
In-hospital case fatality rates – Ischemic stroke The ration between the number of deaths that occurred 
within 30 days of hospital admission with ischemic stroke 
and the number of admissions of ischemic stroke cases 
  
Amenable mortality indicators Definition 
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All causes Number of deaths by all causes 
Infectious diseases Number of deaths caused by infectious diseases 
Cancers Number of deaths caused by cancers 
Endocrine, nutritional and metabolic diseases Number of deaths caused by endocrine, nutritional and 
metabolic diseases 
Diseases of nervous system Number of deaths caused by diseases of nervous system 
Diseases of circulatory system Number of deaths caused by diseases of circulatory system 
Diseases of genitor-urinary system Number of deaths caused by diseases of genitor-urinary 
system 
Diseases of respiratory system Number of deaths caused by diseases of respiratory system 
Diseases of digestive system Number of deaths caused by diseases of digestive system 
Perinatal mortality Number of perinatal deaths per 1000 total births 
  
Prices and physical resources Definition 
Total health expenditure Total health expenditure per capita, USD PPP 
Practicing physicians Density of practicing physicians per 1000 population 
Practicing nurses Density of practicing nurses per 1000 population 
Medical graduates Density of medical graduates per 1000 population 
MRI units Number of magnetic resonance imaging units, per million 
population 
Computed tomography scanners Number of computed tomography scanners, per million 
population 
Number of acute care beds Number of acute care beds per 1000 population 
Remuneration of hospital nurses Nurses’ income per capita GPD 
Remuneration of general practitioners General practitioners’ income per capita GDP 
Remuneration of specialists Specialists’ income per capita GDP 
Relative health prices to GDP Relative health price levels on GDP, 2008 PPP 
benchmark. (It indicates the level of health price relative 
to the general price level in the country) 
  
Activity and consumption indicators Definition 
Spending to GDP Total health expenditure per capita, percentage of GDP 
Doctor consultations Number of doctor consultations per capita 
Hospital discharges Number of hospital discharges of all causes, per 100000 
population 
Hip replacement Number of hip replacement procedures, per 100000 
population 
Knee replacement Number of knee replacement procedures, per 100000 
population 
Appendectomy Number of appendectomy procedures, per 100000 
population 
Caesareans sections Number of caesareans procedures, per 1000 live births 
Antidepressants Consumption of antidepressants, defined daily dosage per 
1 000 inhabitants per day 
Anxiolytics Consumption of anxiolytics, defined daily dosage per 1 
000 inhabitants per day 
Analgesics Consumption of analgesics, defined daily dosage per 1 000 
inhabitants per day 
Antiinflamatory, antirheumatism Consumption of antiinflammatory and antirheumatic 
products non-steroids, defined daily dosage per 1 000 
inhabitants per day 
Antibacterials for systemic use Consumption of antibacterials for systemic use, defined 
daily dosage per 1 000 inhabitants per day 
Cardiovascular system Consumption of pharmaceuticals for the cardiovascular 
system, defined daily dosage per 1 000 inhabitants per day 
Drugs for diabetes Consumption of drugs used in diabetes, defined daily 
dosage per 1 000 inhabitants per day 
  
Financing and spending indicators Definition 
Public spending Percentage of total health expenditure that is financed by 
the general government  
General government funding Percentage of total health expenditure that is financed by 




Social security funding Percentage of total health expenditure that is financed by 
social security funds 
Private health insurance funding Percentage of total health expenditure that is financed by 
private health insurance  
Out-of-pocket payments Percentage of total health expenditure that is financed by 
private households out-of-pocket 
Expenditure on medical goods Percentage of total health expenditure that is spent on 
medical goods 
Expenditure on out-patient care Percentage of total health expenditure that is spent on out-
patient curative and rehabilitative care (the patient that is 
not day case or over-the-night case), on home-care 
services and on ancillary services 
Expenditure on in-patient Percentage of total health expenditure that is spent on in-
patient care (when patients are formally admitted and stay 
for at least one night) and day care (when patients are 
formally admitted for health care and are discharged on the 
same day) 
Expenditure on collective services  Percentage of total health expenditure that is spent on 
prevention, public health services, health administration 
and health insurance 
Source: Joumard et al. (2010); OECD Health Data 2014 
 










* p<0.10, ** p<0.05, *** p<0.01
                                                                                                    
N                             225             225             225             225             225   
R-sqr                       0.791           0.782           0.802           0.797           0.821   
                                                                                                    
                           (0.07)          (0.08)          (0.06)          (0.21)          (0.23)   
constant                    3.998***        3.940***        3.967***        1.980***        1.861***
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.02)   
logNOx                     -0.008          -0.016*         -0.011*         -0.042**        -0.063***
                           (0.01)          (0.01)          (0.01)          (0.03)          (0.03)   
logEdu                      0.050***        0.038***        0.044***        0.149***        0.103***
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.02)   
logDiet                    -0.004          -0.003          -0.003          -0.016          -0.014   
                           (0.01)          (0.02)          (0.01)          (0.03)          (0.04)   
logAlcohol                 -0.013          -0.027          -0.020          -0.040          -0.058   
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.02)   
logSpending                 0.034***        0.045***        0.040***        0.090***        0.118***
                                                                                                    
                             b/se            b/se            b/se            b/se            b/se   
                     Female birth      Male birth     Total birth        Female65          Male65   
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Table A.3 – Fixed effects estimator model with a variable of health stock 
 
Table A.4 – Correlations of health inputs 
 
Figure A.1 – Years of life not explained by the model of fixed-effects estimator (2003) 
Source: Joumard, I. et al. (2008) 
* p<0.10, ** p<0.05, *** p<0.01
                                                                                                    
N                             225             225             225             225             225   
R-sqr                       0.853           0.834           0.859           0.835           0.853   
                                                                                                    
                           (0.05)          (0.11)          (0.07)          (0.27)          (0.33)   
constant                    4.002***        3.963***        3.980***        1.981***        1.862***
                           (0.01)          (0.02)          (0.01)          (0.02)          (0.03)   
logGDP                      0.012           0.010           0.011           0.032           0.036   
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.02)   
logNOx                     -0.007          -0.015          -0.011          -0.042**        -0.063***
                           (0.01)          (0.02)          (0.01)          (0.05)          (0.05)   
logEdu                      0.027**         0.010           0.019           0.091*          0.040   
                           (0.00)          (0.01)          (0.01)          (0.01)          (0.01)   
logDiet                    -0.004          -0.003          -0.004          -0.017          -0.015   
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.03)   
logAlcohol                 -0.009          -0.021*         -0.016          -0.031          -0.048*  
                           (0.01)          (0.02)          (0.01)          (0.02)          (0.03)   
logStock                    0.032***        0.041**         0.037***        0.078***        0.086** 
                           (0.01)          (0.01)          (0.01)          (0.02)          (0.03)   
logSpending                -0.006          -0.003          -0.004          -0.010           0.009   
                                                                                                    
                             b/se            b/se            b/se            b/se            b/se   
                     Female birth      Male birth     Total birth        Female65          Male65   
                                                                                                    
         gdp     0.7710   0.7789   0.1321   0.0093   0.1793   0.2620   1.0000
         nox     0.2505   0.2598  -0.1014   0.0356  -0.0236   1.0000
   education     0.2229   0.2137   0.2397  -0.5935   1.0000
        diet    -0.0614  -0.0498  -0.4569   1.0000
     alcohol     0.0973   0.0785   1.0000
       stock     0.9939   1.0000
    spending     1.0000
                                                                             
               spending    stock  alcohol     diet educat~n      nox      gdp
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1 country 1 = Australia; country 2 = Austria; country 3 = Belgium ; country 4 = Canada;  
country 5 = Czech Republic; country 6 = Denmark; country 7 = Estonia; country 8 = Finland;  
country 9 = France; country 10 = Germany; country 11 = Greece; country 12 = Hungary; 
country 13 = Iceland; country 14 = Ireland; country 15 = Israel; country 16 = Italy ; country 17 = Japan; 
country 18 = Korea; country 19 = Luxembourg; country 20 = Mexico; country 21 = Netherlands;  
country 22 = New Zealand; country 23 = Norway; country 24 = Poland; country 25 = Portugal; 
country 26 = Slovak Republic; country 27 = Slovenia; country 28 = Spain; country 29 = Sweden;  
country 30 = Switzerland; country 31 = Turkey; country 32 = United Kingdom; country 33 = United States 
of America 
* p<0.10, ** p<0.05, *** p<0.01
                                    
N                             225   
R-sqr                               
                                    
                        (1083.59)   
constant                  -39.784   
                        (1083.59)   
group(country)=33          34.070   
                        (1083.59)   
group(country)=32          31.722   
                        (1083.59)   
group(country)=31          35.138   
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                        (1083.62)   
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group(country)=15          29.317   
                        (1083.59)   
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                       (12955.87)   
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group(country)=9           29.409   
                        (1083.59)   
group(country)=8           32.193   
                        (1083.59)   
group(country)=7           34.270   
                        (1083.59)   
group(country)=6           33.351   
                        (1083.59)   
group(country)=5           33.473   
                        (1083.59)   
group(country)=4           29.086   
                        (1083.59)   
group(country)=3           32.491   
                        (1083.59)   
group(country)=2           31.057   
                              (.)   
group(country)=1            0.000   
lnsig2u                             
                                    
                           (0.25)   
constant                  -11.473***
lnsig2v                             
                                    
                           (0.10)   
constant                    4.407***
                           (0.01)   
logGDP                      0.010   
                           (0.00)   
logNOx                     -0.008***
                           (0.00)   
logEdu                     -0.018***
                           (0.00)   
logDiet                    -0.028***
                           (0.00)   
logAlcohol                 -0.017***
                           (0.01)   
logSpending                 0.022***
logLEtotal                          
                                    
                             b/se   
                              SFA   
                                    
* p<0.10, ** p<0.05, *** p<0.01
                                    
N                         225.000   
                                    
                        (1083.59)   
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Figure A.2 - Potential gains in life expectancy at birth across and within country groups 
plot (DEA), 2007 
 
Source: Joumard, I., C. André and C. Nicq (2010) 
 
 
Table A.6 – Descriptive statistics of inputs and outputs 
 
 
    le_mal65         231    17.03636     1.54345       13.1       19.3
    le_fem65         231    20.47056    1.588409       15.6         24
 le_malbirth         231    76.45238    3.076557       67.5       80.7
 le_fembirth         231    82.15541    2.271555       75.2       86.4
le_totalbi~h         231    79.32641    2.589468       72.9         83
                                                                      
         gdp         231    33654.81    12891.13    10840.8    88848.1
         nox         225    29.07467    16.96752        9.6       86.7
   education         231    73.31004     17.0898      26.44        100
        diet         231    224.3026    59.76859      132.9      433.8
     alcohol         231    9.516883    2.809614        1.2       14.8
       stock         231    6886.944    3306.759   1151.895   19587.48
    spending         231    3100.376    1444.802   590.6946   8482.719
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
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2 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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3 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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4 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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Figure A.6 - Health indicators: Canada, 2011 (or latest year available)5 
                                                          
5 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 










                                                          
6 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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7 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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8 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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9 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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10 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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11 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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12 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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13 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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14 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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15 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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16 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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17 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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18 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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19 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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20 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
26 
 




                                                          
21 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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22 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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23 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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24 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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25 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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26 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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27 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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28 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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29 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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30 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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31 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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32 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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33 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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34 In the graphs representing Activity consumption, Amenable mortality, Prices and physical resources and 
Financing and spending, the points outside the average circle mean that the indicators are higher than the 
OECD average. In the graph representing Efficiency and quality, the points outside the average circle mean 
that the country is doing better than the OECD average of that indicator (e.g. low fatality rates are placed 
outside the average circle; low administration costs are placed outside the average circle). 
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